Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits.

James Nicholas BrentonDiana Lehner-GulottaEmma WoolbrightBrenda BanwellA G Christina BergqvistShanshan ChenRachael ColemanMark ConawayMyla D Goldman

Published in: Journal of neurology, neurosurgery, and psychiatry (2022)

Registered on ClinicalTrials.gov under registration number NCT03718247, posted on 24 October 2018. First patient enrolment date: 1 November 2018. Link: https://clinicaltrials.gov/ct2/show/NCT03718247?term=NCT03718247&draw=2&rank=1.

Keyphrases

multiple sclerosis
phase ii study
open label
locally advanced
placebo controlled
white matter
computed tomography
case report
health insurance
image quality
weight loss
clinical trial
contrast enhanced
randomized controlled trial
double blind
dual energy
study protocol
rheumatoid arthritis
climate change